End-of-day quote
Shanghai S.E.
06:00:00 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
9.97
CNY
|
-1.29%
|
|
-6.30%
|
-25.43%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,211
|
2,491
|
2,761
|
2,210
|
2,723
|
2,170
|
Enterprise Value (EV)
1 |
2,622
|
1,867
|
2,118
|
1,741
|
2,151
|
1,723
|
P/E ratio
|
18.8
x
|
69.8
x
|
11.5
x
|
18.9
x
|
27.5
x
|
-55.7
x
|
Yield
|
1.31%
|
0.42%
|
2.11%
|
1.3%
|
0.42%
|
-
|
Capitalization / Revenue
|
2.44
x
|
2.88
x
|
1.85
x
|
1.46
x
|
1.59
x
|
1.81
x
|
EV / Revenue
|
1.99
x
|
2.16
x
|
1.42
x
|
1.15
x
|
1.26
x
|
1.44
x
|
EV / EBITDA
|
13.2
x
|
28.4
x
|
6.88
x
|
9.52
x
|
13.2
x
|
67.5
x
|
EV / FCF
|
68.6
x
|
5.29
x
|
45.7
x
|
-7.48
x
|
-67.2
x
|
-109
x
|
FCF Yield
|
1.46%
|
18.9%
|
2.19%
|
-13.4%
|
-1.49%
|
-0.92%
|
Price to Book
|
2.9
x
|
2.26
x
|
2.06
x
|
1.56
x
|
1.7
x
|
1.39
x
|
Nbr of stocks (in thousands)
|
156,800
|
162,690
|
162,727
|
162,349
|
162,294
|
162,312
|
Reference price
2 |
20.48
|
15.31
|
16.96
|
13.61
|
16.78
|
13.37
|
Announcement Date
|
4/25/19
|
4/26/20
|
3/30/21
|
4/6/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,317
|
865.8
|
1,494
|
1,518
|
1,709
|
1,196
|
EBITDA
1 |
198.3
|
65.72
|
307.9
|
182.8
|
163.2
|
25.55
|
EBIT
1 |
161.7
|
22.41
|
258.4
|
119.2
|
98.6
|
-45.91
|
Operating Margin
|
12.28%
|
2.59%
|
17.29%
|
7.85%
|
5.77%
|
-3.84%
|
Earnings before Tax (EBT)
1 |
162.9
|
41.05
|
274.8
|
132.2
|
100.5
|
-47.78
|
Net income
1 |
138.8
|
34.76
|
235.7
|
114.7
|
99.23
|
-39.16
|
Net margin
|
10.54%
|
4.01%
|
15.77%
|
7.56%
|
5.81%
|
-3.27%
|
EPS
2 |
1.092
|
0.2194
|
1.471
|
0.7200
|
0.6100
|
-0.2400
|
Free Cash Flow
1 |
38.22
|
353.1
|
46.37
|
-232.7
|
-32.03
|
-15.81
|
FCF margin
|
2.9%
|
40.79%
|
3.1%
|
-15.33%
|
-1.87%
|
-1.32%
|
FCF Conversion (EBITDA)
|
19.27%
|
537.28%
|
15.06%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
27.54%
|
1,015.86%
|
19.68%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2679
|
0.0643
|
0.3571
|
0.1770
|
0.0700
|
-
|
Announcement Date
|
4/25/19
|
4/26/20
|
3/30/21
|
4/6/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
590
|
624
|
643
|
469
|
572
|
447
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
38.2
|
353
|
46.4
|
-233
|
-32
|
-15.8
|
ROE (net income / shareholders' equity)
|
16.8%
|
3.14%
|
19.3%
|
8.31%
|
6.56%
|
-2.56%
|
ROA (Net income/ Total Assets)
|
7.72%
|
0.92%
|
9.13%
|
3.74%
|
2.64%
|
-1.07%
|
Assets
1 |
1,799
|
3,761
|
2,580
|
3,071
|
3,752
|
3,657
|
Book Value Per Share
2 |
7.070
|
6.770
|
8.230
|
8.750
|
9.860
|
9.600
|
Cash Flow per Share
2 |
2.260
|
2.310
|
3.960
|
2.250
|
4.340
|
5.220
|
Capex
1 |
77.3
|
89.3
|
137
|
140
|
164
|
140
|
Capex / Sales
|
5.87%
|
10.32%
|
9.16%
|
9.25%
|
9.62%
|
11.69%
|
Announcement Date
|
4/25/19
|
4/26/20
|
3/30/21
|
4/6/22
|
4/28/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -25.43% | 230M | | -1.54% | 3.47B | | -24.51% | 2.01B | | -10.52% | 1.92B | | -2.34% | 1.78B | | -1.86% | 1.65B | | -12.45% | 1.2B | | -0.48% | 1.14B | | -23.14% | 1.02B | | -6.09% | 954M |
Pesticide
|